( in Million)
Particulars
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
497.88
76.32
180.9
698.9
Total Expenditure
676.83
69.91
32.94
37.43
PBIDT (Excl OI)
-178.95
6.41
147.96
661.47
Other Income
35.99
0.01
0.02
0.04
Operating Profit
-142.96
6.42
147.99
661.51
Exceptional Items
NA
NA
NA
NA
PBDT
-169.59
6.42
147.24
661.29
Depreciation
45.4
0.36
0.28
0.28
Profit Before Tax
-214.99
6.06
146.96
661.01
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-354.96
-3.09
109.8
502.08
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
-354.96
-3.09
109.8
502.08
Minority Interest
4.06
2.11
1.7
1.94
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
-350.9
-0.98
111.5
504.04
Equity Capital
447.27
447.27
381.92
381.92
Face Value (IN RS)
10
10
10
10
Calculated EPS
-7.84
-0.02
2.91
13.19
Calculated EPS (Annualised)
-31.38
-0.08
11.67
52.79
No of Public Share Holdings
18788375
18788375
18759474
18759474
% of Public Share Holdings
42.01
42.01
49.12
49.12
PBIDTM% (Excl OI)
-35.94
8.39
81.79
94.64
PBIDTM%
-28.71
8.41
81.80
94.65
PBDTM%
-34.06
8.41
81.39
94.61
PBTM%
-43.18
7.94
81.23
94.57
PATM%
-71.29
-4.04
60.69
71.83